
Draig Therapeutics
Developer of a biotechnology platform designed to deliver effective treatments for neuropsychiatric disorders. The company's platform specializes in developing in-class modulators of the primary excit...
Valuation
$0
Share Price
N/A
Total Raised
$165.9M
Last Round
N/A